VYNE Therapeutics Inc (VYNE)

[jugs]

For some reason I'd expected thing to have moved well ahead of this news with Q1 approval---if granted---to come much earlier than the news indicates is even possible. We're looking at 40 weeks following selection of phase 3 candidates. Then there's the time necessary for extensive evaluation plus submission for FDA approval. And, of course, VYNE could be handed a paper (CRL) requiring additional hoops be confronted.

I am slightly disappointed. But as I think about it, I'm realizing my expectations have been unreasonable so it is I who must make the necessary adjustment (s), never as easy as it sounds when you have big money invested in 27 shares. lol

I guess I will survive.